Fast Five Quiz: The Recurrence Risks for Breast Cancer

Elwyn C. Cabebe, MD; Stefania Morganti, MD


February 06, 2023

ER-positive early-stage breast cancer is associated with risk for late recurrence (more than 5 years after diagnosis). Considering all subtypes of breast cancer, most recurrences occur within the first 5 years after diagnosis. In triple-negative breast cancer, most recurrences happen within 3 years after diagnosis.

Childbearing after treatment for invasive breast cancer does not increase rates of recurrence.

Tamoxifen does reduce the risk for recurrence after diagnosis of hormone receptor–positive breast cancer.

Learn more about breast cancer recurrence risk.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.